[November 19, 2009] xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 18, 2009 : ECTE, GLTC, SPWRA and CERP Tweet Nov 19, 2009 (M2 PRESSWIRE via COMTEX) -- Xtremepicks.com Alerts include Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), GelTech Solutions, Inc. (OTC Bulletin Board: GLTC), SunPower Corp. (Nasdaq: SPWRA, SPWRB) and Cereplast, Inc. (OTCBB: CERP) Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE) trading at $1.38 per share on trading volume of 89,485 shares. In a press release out on November 18, Echo Therapeutics Announces Positive Results of a Clinical Study Testing Symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes FRANKLIN, Mass., Nov 19, 2009 -- Study Demonstrates Improvement of Accuracy with New Biosensor Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced positive results of a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 Diabetes. Echo's non-invasive Symphony tCGM System consists of its wireless transmission and transdermal biosensor technologies and its Prelude SkinPrep System, which incorporates leading-edge, needle-free, controlled skin ablation. Echo's Symphony tCGM System is designed to provide patients with diabetes and critical care patients with a reliable, affordable, and easy-to-use, needle-free continuous glucose monitoring device. The purpose of the study was to test the performance of its new, improved one-piece, cost-effective and easy-to-use biosensor. About Echo Therapeutics Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in acute and critical care. Echo's non-invasive Symphony tCGM System consists of its Prelude SkinPrep System, which incorporates patented and leading-edge skin ablation control technology, and wireless transmission and proprietary transdermal biosensor technologies. Echo's Symphony tCGM System is designed to provide both diabetes and hospital patients with a reliable, needle-free, easy-to-use, affordable and comfortable-to-wear continuous glucose monitoring device. Echo is also developing its needle-free Prelude SkinPrep System for transdermal drug delivery of a wide range of novel topical reformulations of widely-used, FDA-approved products. GelTech Solutions, Inc. (OTC Bulletin Board: GLTC) trading at $1.74 per share on trading volume of 3,370 shares. In a press release out on November 18, GelTech Solutions Aligns with Fisher Safety JUPITER, Fla., Nov 19, 2009 -- GelTech Solutions, Inc. (OTC Bulletin Board: GLTC) is pleased to announce that it has aligned with Fisher Safety for the sales and distribution of its patented fire suppressant FireIce in the Southeast and Southwest marketplaces. About GelTech: GelTech Solutions' creates innovative, Earth-friendly, cost-effective products that help industry, agriculture, and the general public accomplish environmental and safety goals, such as water conservation and the protection of lives, homes, and property from fires. Its two leading products are FireIce(R) and RootGel. SunPower Corp. (Nasdaq: SPWRA, SPWRB) trading at $21.76 on a volume of 1.63M shares In a press release out on November 18, SunPower Completes 1-Megawatt Solar Power System at Agilent Technologies Headquarters --Santa Clara Campus Installation Features SunPower T5 Solar Roof Tile, the Solar Industry's Most Powerful Rooftop System SAN JOSE, Calif., Nov 19, 2009 -- SunPower Corp. (Nasdaq: SPWRA, SPWRB), a Silicon Valley-based manufacturer of high-efficiency solar cells, solar panels and solar systems, today announced the completion of a 1-megawatt solar power rooftop system on three buildings at Agilent's headquarters in Santa Clara, Calif. This is SunPower's second project with Agilent, following the design and installation of a 1-megawatt solar tracking system at Agilent's Santa Rosa, Calif., campus last year. Agilent expects to save $3.5 million in energy costs in the first 10 years of operation. About SunPower Founded in 1985, SunPower Corp. (Nasdaq: SPWRA, SPWRB) designs, manufactures and delivers the planet's most powerful solar technology broadly available today. Residential, business, government and utility customers rely on the company's experience and proven results to maximize return on investment. With headquarters in San Jose, Calif., SunPower has offices in North America, Europe, Australia and Asia. For more information, visit www.sunpowercorp.com. Cereplast, Inc. (OTCBB:CERP) trading at $0.10 on a volume of 126,880 shares In a press release out on November 18, Study Estimates Bio-Plastics Could Eliminate Up to 90% of Existing Petroleum-Based Plastics Cereplast to Benefit by Replacing Traditional, Non-Sustainable Products with Competitively Priced Compostables(R) and Hybrid(R) Resins HAWTHORNE, Calif., Nov 19, 2009 -- Cereplast, Inc. (OTCBB:CERP), a leading manufacturer of proprietary bio-based, sustainable plastics, announced today that a recent study from the European Bioplastics and the European Polysaccharide Network of Excellence (EPNOE) estimates that current technology may make it possible for up to 90% of total plastics consumed could be replaced by bio-based polymers. About Cereplast, Inc. Cereplast, Inc. (OTCBB:CERP) designs and manufactures proprietary bio-based, sustainable plastics which are used as substitutes for petroleum-based plastics in all major converting processes - such as injection molding, thermoforming, blow molding and extrusions - at a pricing structure that is competitive with petroleum-based plastics. On the cutting-edge of bio-based plastic material development, Cereplast now offers resins to meet a variety of customer demands. Cereplast Compostables Resins(R) are ideally suited for single use applications where high bio-based content and compostability are advantageous, especially in the food service industry. Cereplast Hybrid Resins(R) combine high bio-based content with the durability and endurance of traditional plastic, making them ideal for applications in industries such as automotive, consumer electronics and packaging. Learn more at www.cereplast.com. Xtremepicks.com profiles early stage microcap and growth stocks that provide innovative products or services resulting in potentially "hyper-growth" opportunities. Often, these companies have yet to be recognized by Wall Street and the undiscovered nature of Xtremepicks.com's profile companies provide our members the opportunity to learn about these companies at their development stage, and more importantly before they possibly "turn the corner" and get exposed to a much larger investing audience. Xtremepicks.com (www.Xtremepicks.com) has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by Xtremepicks.com to be accurate, and should not be considered to be all-inclusive. Xtremepicks.com is a leading information resource for evaluating investment opportunities in small and microcap stocks. We focus on a limited number of companies in order to provide comprehensive coverage, including unique investment related features not available anywhere else on the Internet. To feature a company or to get more information, please visit us at www.Xtremepicks.com or email us at [email protected] Xtremepicks.coms affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Xtremepicks.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. To view full disclaimers, go to http://www.Xtremepicks.com/disclaimer.htm CONTACT: Xtremepicks.com e-mail: [email protected] WWW: http://www.Xtremepicks.com ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected]. [ Back To TMCnet.com's Homepage ]